Polyunsaturated fatty acids can be oxygenated by cytochrome P450 to hy
droxy and epoxy fatty acids. Two major classes of hydroxy fatty acids
are formed by hydroxylation of the omega-side chain and by hydroxylati
on of bisallylic methylene carbons. Bisallylic cytochrome P450-hydroxy
lases transform linoleic acid to 11-hydroxylinoleic acid, arachidonic
acid to 13-hydroxyeicosa-5Z,8Z,11Z,14Z-tetraenoic acid, 10-hydroxyeico
sa-5Z,8Z,11Z,14Z-tetraenoic acid and 7-hydroxyeicosa-5Z,8Z,11Z,14Z-tet
raenoic acid and eicosapentaenoic acid to 16-hydroxyeicosa-5Z,8Z,11Z,1
4Z,17Z-pentaenoic acid, 13-hydroxyeicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic
acid and 10-hydroxyeicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic acid as major m
etabolites. The bisallylic hydroxy fatty acids are chemically unstable
and decompose rapidly to cis-trans conjugated hydroxy fatty acids dur
ing acidic extractive isolation. Bisallylic hydroxylase activity appea
rs to be augmented in microsomes induced by the synthetic glucocortico
id dexamethasone and by some other agents, but the P450 gene families
of these hydroxylases have yet to be determined. The fatty acid epoxid
es, which are formed by cytochrome P450, are chemically stable, but ar
e hydrolyzed to diols by soluble epoxide hydrolases. Epoxidation of po
lyunsaturated fatty acids is a prominent pathway of metabolism in the
liver and the renal cortex and epoxygenase-activity appears to be unde
r homeostatic control in the kidney. Many arachidonate epoxygenases ha
ve been identified belonging to the CYP2C gene subfamily. Epoxygenases
have also been found in the central nervous system, endocrine organs,
the heart and endothelial cells. Epoxides of arachidonic acid have be
en found to exert pharmacological effects on many cells.